Search results
Weight Loss Drugs Like Wegovy and Ozempic May Change Sense of Taste
Prevention via Yahoo News· 7 hours agoWeight loss drugs like Wegovy and Ozempic may change sense of taste and how the brain reacts to...
Novo’s Blockbuster Obesity Drug Wegovy Under Fire in Denmark
Bloomberg· 7 hours agoA Danish drug oversight panel advised doctors to restrict prescriptions of Novo Nordisk A/S’s...
Pfizer, Flagship to focus on obesity drugs under $100M collaboration - Boston Business Journal
The Business Journals· 1 day agoAlmost a year after Cambridge’s Flagship Pioneering and Pfizer Inc. announced a partnership to...
Flagship taps startup to hunt for obesity drugs that might interest Pfizer
BioPharma Dive via Yahoo Finance· 1 day agoThe venture firm will work with ProFound Therapeutics to “rapidly surface” protein drug candidates...
Why Blue Cross of Michigan is axing coverage of popular weight loss drugs
Detroit News· 1 day agoBlue Cross Blue Shield of Michigan is dropping coverage of popular weight loss drugs, citing...
Employer coverage for weight-loss drugs rises sharply, survey finds
Reuters via Yahoo Finance· 46 minutes agoAbout one-third of U.S. employer health plans are offering coverage of GLP-1 drugs for both diabetes...
Anti-obesity drugs will be 2024’s defining trend
Clinical Trials Arena via Yahoo Finance· 1 day agoGlobalData’s latest update notes the impact of the growing anti-obesity market, personalised medicines, real-world evidence, and cell and gene therapies.
Thousands in one state to lose weight loss drug coverage
Newsweek· 4 hours agoThousands of people in Michigan who use popular weight loss drugs will soon lose their coverage for...
Michigan’s largest insurer to drop weight-loss drug coverage
Chicago Tribune· 1 day agoWeight-loss drugs from Novo Nordisk A/S and Eli Lilly & Co. will lose coverage under many plans run...
New KFF Analysis Finds Costly GLP-1 Drugs ( includes Wegovy and Ozempic) are Rarely Covered for...
Sierra Sun Times· 6 hours agoAffordable Care Act (ACA) Marketplace plans rarely cover GLP-1 drugs approved solely for obesity treatment, according to a new KFF analysis of 2024 federal plan data. Wegovy ...